Historial de carrera de Carolyn Finkle
Antiguos cargos conocidos de Carolyn Finkle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Consejero General | 14/03/2022 | 27/12/2023 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director de Operaciones | 01/01/2019 | 01/01/2021 |
| Consejero General | 01/01/2019 | 01/01/2021 | |
| PRECIGEN, INC. | Consejero General | - | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| IMUNON, INC. | Consejero General | - | - |
Formación de Carolyn Finkle.
| University of Ottawa | Undergraduate Degree |
| University of Toronto | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Canadá | 4 |
Operativa
| General Counsel | 4 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| IMUNON, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Carolyn Finkle
- Experiencia
